Elderly, Health Services for the Aged, Hospital Readmission, Medication Safety, Pharmaceutical Care
Conditions
Keywords
medication safety, elderly, pharmaceutical care, hospital readmission, drug-related readmission, Health Services for the Aged
Brief summary
The purpose of this study is to determine whether additional pharmaceutical care for elderly patients (home-cared patients, nursing-home residents) has a positive impact on drug-related readmissions.
Interventions
Checking medication under safety considerations (medication at admission, hospitalization, discharge); recommendations for potentially inappropriate medication (PRISCUS-criteria),
Sponsors
Apothekerstiftung Nordrhein, Duesseldorf
Foerderinitiative Pharmazeutische Betreuung e.V., Berlin
RWTH Aachen University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* patient 65 years old or older * patient admitted to one of the project wards * minimum hospitalization: 3 days * written informed consent (patient or the legal representative) * current medication of the patient at hospitalization
Exclusion criteria
* patients included in this study previously
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Drug-related readmission | one year after discharge from the cooperating ward |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of prescribed potentially inappropriate medication (PRISCUS-criteria) | during hospital stay on cooperating wards(continuous data collection during routine ward rounds;hence,duration of data collection is dependent on individual hospital stay of each patient, up to 1 year) and 1 year after discharge from the cooperating ward | The PRISCUS list was developed in 2010 for the German market. Potentially inappropriate medications were judged as inappropriate by an expert panel using the Delphi technique. \[Holt et al., Dtsch Arztebl 2010\] |
| time to readmission | one year after discharge from the cooperating ward | — |
| Number of accepted recommendations in the intervention group | during hospital stay on cooperating wards (continuous data collection during routine ward rounds; hence, duration of data collection is dependent on individual hospital stay of each patient, up to one year) in the intervention group | — |
| Adverse drug events | during hospital stay on cooperating wards(continuous data collection during routine ward rounds;hence,duration of data collection is dependent on individual hospital stay of each patient, up to 1 year) and 1 year after discharge from the cooperating ward | — |
| drug-related problem | during hospital stay on cooperating wards (continuous data collection during routine ward rounds; hence, duration of data collection is dependent on individual hospital stay of each patient, up to one year) in the intervention group | — |
| number of changes in medication after discharge | one year | — |
| time for intervention | during hospital stay on cooperating wards (continuous data collection during routine ward rounds; hence, duration of data collection is dependent on individual hospital stay of each patient, up to one year) in the intervention group | time recording for pharmaceutical care service |
Countries
Germany
Outcome results
None listed